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Abstract Myeloic cells express a peculiar surface receptor for
extracellular ATP, called the P2Z/P2X7 purinoreceptor, which
is involved in cell death signalling. Here, we investigated the role
of caspases, a family of proteases implicated in apoptosis and the
cytokine secretion. We observed that extracellular ATP induced
the activation of multiple caspases including caspase-1, -3 and -8,
and subsequent cleavage of the caspase substrates PARP and
lamin B. Using caspase inhibitors, it was found that caspases
were specifically involved in ATP-induced apoptotic damage such
as chromatin condensation and DNA fragmentation. In contrast,
inhibition of caspases only marginally affected necrotic altera-
tions and cell death proceeded normally whether or not nuclear
damage was blocked. Our results therefore suggest that the
activation of caspases by the P2Z receptor is required for
apoptotic but not necrotic alterations of ATP-induced cell death.
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1. Introduction
The P2Z/P2X7 receptor for extracellular ATP belongs to
the family of purinergic receptors which exert a wide range
of biological activities including mitogenic stimulation, excita-
tory transmitter function, cytokine secretion and induction of
cell death [1^4]. It contains two transmembrane domains and
a large extracellular loop, structural features that are charac-
teristic of members of the P2X family. Unlike other P2X
receptors, the P2Z receptor has an unusually long C-terminal
domain which does not contain known signalling motifs. P2Z
receptor expression is rather restricted to the macrophage lin-
eage, such as dendritic cells, macrophages and microglial cells.
Triggering of the P2Z receptor elicits two types of cellular
responses [3]. Like with all P2X receptors, the ligation of
ATP results in a transient membrane current through divalent
cation channels. A second and unique response is the sus-
tained membrane depolarization and the increase in cytosolic
free calcium by the opening of a transmembrane pore which is
permeable to hydrophilic molecules of a molecular weight up
to 900 Da. Important activities of the P2Z receptor include
the release of IL-1L [5^7] and induction of cell death [8,9].
Recent studies have shown that both the release of IL-1L
and the induction of apoptotic cell death are controlled by a
family of intracellular proteases, called caspases [10]. In mam-
malian cells, at least 13 caspases exist, which are cysteine
proteases that cleave their substrates after aspartate residues.
Caspases are synthesized as inactive pro-enzymes and proteo-
lytically processed to form an active complex composed of
two heterodimeric subunits of about 10 and 20 kDa. A num-
ber of proteins are cleaved by caspases and for some of them
an apoptotic function could be attributed. Among di¡erent
substrates are enzymes involved in genome function and
DNA repair, regulators of the cell cycle, structural proteins
and the inhibitory subunit of a novel endonuclease, designated
CAD for caspase-activated DNase [11].
In this study, we investigated the role of caspases in re-
sponse to P2Z receptor activation in microglial cells. So far,
the signal transduction pathways elicited by the P2Z receptor
are largely unknown. While it is established that caspases play
a crucial e¡ector function in many apoptotic pathways, their
role in necrosis and lytic membrane alterations is rather un-
clear. We found that activation of the P2Z receptor rapidly
induced apoptotic DNA fragmentation, accompanied by the
proteolytic processing of multiple caspases and caspase sub-
strates. Inhibitors of caspases speci¢cally suppressed DNA
fragmentation and other morphological signs of apoptotic
damage. In contrast, cytoplasmic vacuolization and cell lysis
remained una¡ected and cell death proceeded normally
whether or not the caspase activation was blocked. Interest-
ingly, activation of caspase-1 but not caspase-3 appeared to
involve the proteasome pathway, since a speci¢c inhibitor of
the proteasome function prevented caspase-1 processing. Col-
lectively, our results suggest that P2Z receptor ligation causes
the activation of multiple caspases, which are regulated by
di¡erent pathways and are required for apoptotic but not
necrotic alterations during ATP-induced cell death.
2. Materials and methods
2.1. Cell culture and reagents
The mouse microglial cell line N13 [12] was provided by Dr Ric-
ciardi-Castagnoli (University of Milan, Italy) and grown in RPMI
1640 medium supplemented with 10% FCS. ATP and other nucleo-
tides were purchased from Boehringer-Mannheim (Mannheim, Ger-
many). The protease inhibitors YVAD (N-acetyl-Tyr-Val-Ala-Asp-
chloromethylketone), DEVD (N-acetyl-Asp-Glu-Val-Asp-aldehyde)
and zVAD (benzyloxycarbonyl-Val-Ala-Asp-(OMe)£uoro-methylke-
tone) were obtained from Bachem (Heidelberg, Germany) and En-
zyme Systems (Dublin, CA, USA). The proteasome inhibitor lacta-
cystin was obtained from Calbiochem (Bad Soden, Germany). Rabbit
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anti-PARP and mouse anti-lamin B were purchased from Boehringer-
Mannheim and Camon (Wiesbaden, Germany), respectively. Antibod-
ies to caspase-1 and caspase-3 were produced by immunizing rabbits
with the recombinant proteins. An antibody against caspase-8 was
obtained from Biomedia (Baesweiler, Germany).
2.2. Immunoblotting
Proteolytic processing of caspases and caspase substrates was de-
tected by Western blotting as described [13]. Cell extracts were sepa-
rated by SDS-PAGE and transferred to PVDF membranes. Mem-
branes were blocked for 1 h with 5% non-fat dry milk powder in
TBS, incubated with the respective primary and secondary antibodies
and stained by enhanced chemoluminescent staining.
2.3. Gel electrophoresis of fragmented DNA
After the indicated treatments, cells were trypsinized and collected
together with the £oating cells in the supernatant. DNA was extracted
from the cells by the salting out technique [14].
2.4. Measurement of DNA fragmentation by BrdU release
DNA fragmentation was quanti¢ed by the release of 5P-bromo-2P-
deoxyuridine (BrdU) using the commercial cellular DNA fragmenta-
tion ELISA kit (Boehringer-Mannheim) according to the manufactur-
er’s instructions.
2.5. Measurement of LDH release
The cell viability was determined by measuring the release of lactate
dehydrogenase (LDH) using a cytotoxicity detection kit (Boehringer-
Mannheim). The LDH activity released from dead cells was measured
spectrophotometrically in the supernatants according to the manufac-
turer’s instructions. In order to obtain the total LDH activity, cells
were lysed with 1% Triton X-100. The percentage of LDH release
represents the fraction of LDH activity found in the supernatants
with respect to the overall enzyme activity.
2.6. Measurement of hypodiploid DNA
Fragmentation of genomic DNA to hypodiploid DNA was assessed
by FACS analysis [15]. After the desired cell treatments, cells were
washed with PBS, ¢xed for 30 min in cold acetone-methanol (1:1) and
incubated for 1 h in RNase A (1 mg/ml) and propidium iodide (100
Wg/ml).
2.7. Morphological detection of cell death
Cells were grown on coverslips and treated with ATP in the pres-
ence and absence of zVAD. Cells were then washed carefully in PBS,
¢xed for 10 min in methanol/ethanol (1:1) and stained with the DNA
dye Hoechst 33342 (Sigma, Deisenhofen, Germany) in the presence of
0.1 mg/ml RNase. After 15 min, cells were mounted in Mowiol
(Hoechst, Frankfurt, Germany) and inspected by phase contrast and
£uorescent light microscopy.
3. Results and discussion
3.1. Extracellular ATP causes DNA fragmentation upon P2Z
receptor ligation
A most striking e¡ect of ATP is the induction of cell death
which can be triggered by di¡erent purinoreceptors. We in-
vestigated ATP-induced cell death in the mouse microglial cell
line N13 that expresses P2Y and P2Z purinoreceptors [9]. In
initial experiments, the induction of cell death was analyzed
by measuring the DNA fragmentation following cell treat-
ment with ATP and other nucleotides for 6 h. As revealed
by DNA gel electrophoresis, treatment of cells with 3 mM
ATP caused the appearance of a classical DNA ladder (Fig.
1A). DNA fragmentation was not observed with lower con-
centrations of ATP and also other nucleotides were unable to
induce DNA fragmentation or other features of cell death. In
particular, UTP that activates also the P2Y receptor did not
induce DNA fragmentation (Fig. 1A), indicating that cell
death was speci¢cally mediated by the P2Z receptor. This
assumption was supported by other ¢ndings. ATPQS, a non-
hydrolysable ATP derivative, also induced cell death, demon-
strating that degradation of ATP was not required (data not
shown). In contrast, oxidized ATP, which inhibits the P2Z
receptor [16], prevented ATP-induced DNA fragmentation.
Furthermore, neither DNA cleavage nor other cytotoxic fea-
tures were induced in derivative cell clones that lack the P2Z
receptor but still express P2Y purinergic receptors ([9], data
not shown). Induction of cell death was also observed by
measuring the formation of hypodiploid DNA. FACS analy-
sis revealed that 3 mM ATP induced the formation of hypo-
diploid DNA in about 30% of the cells within 4 h (Fig. 1B). A
dose-dependent increase of this apoptotic alteration is demon-
strated in Fig. 1C.
3.2. Involvement of caspases in ATP-induced cell death
Since caspases have been implicated as the principal medi-
ators of apoptosis, we ¢rst investigated the cleavage of known
caspase substrates during ATP-induced cell death. Poly(ADP-
ribose)polymerase (PARP), a DNA repair enzyme, has been
shown to serve as a substrate for caspase-3 [17]. Fig. 2A
demonstrates that PARP, a 116 kDa protein, was cleaved
into the characteristic 89 kDa fragment in the course of
ATP treatment. Another substrate comprises lamin B, a com-
ponent of the nuclear envelope, which can be cleaved by casp-
ase-6 [18]. A marked cleavage of lamin B, a 66 kDa protein,
into its 46 kDa fragment occurred within 4 h following ATP
treatment (Fig. 2A).
Caspases are synthesized as inactive zymogens and con-
verted to an active tetrameric complex composed of two het-
erodimeric subunits. As shown in Fig. 2B, ATP treatment of
N13 cells resulted in the conversion of the inactive caspase-1
precursor to the proteolytically cleaved p20 subunit. Process-
ing was maximal after 3 h and thereafter declined. In contrast,
proteolytic processing of caspase-3 from the 32 kDa zymogen
to the 17 kDa subunit occurred with a slightly di¡erent kinetic
and was most pronounced after 5 h (Fig. 2B). We also inves-
tigated the processing of caspase-8, the most proximal caspase
during CD95-mediated apoptosis. Caspase-8 is synthesized as
a precursor of 54 kDa and, following formation of a 43 kDa
intermediate cleavage product, processed to a p18 and p10
heterodimer [19]. In untreated N13 cells, an antibody against
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Fig. 1. Extracellular ATP but not other nucleotides induce apoptotic
DNA fragmentation in N13 cells. (A) Gel electrophoresis of ge-
nomic DNA. Cells were incubated with the indicated concentrations
of ATP and other nucleotides. DNA was isolated after 6 h. (B) De-
tection of hypodiploid DNA. Typical histograms of control cells
(upper panel) and cells treated for 4 h with 3 mM ATP (lower pan-
el) are shown. (C) Dose-dependent e¡ect of ATP on the formation
of hypodiploid DNA. Cells were incubated for 6 h with the indi-
cated concentrations of ATP.
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the p18 subunit detected a doublet protein band of about 54
kDa representing procaspase-8a and -8b [20]. ATP treatment
of N13 cells resulted in the conversion of the protein doublet
to proteins of about 43 kDa corresponding to the intermedi-
ate cleavage products (Fig. 2B). So far, activation of caspase-8
appeared to be restricted to apoptosis triggered by death re-
ceptors [21]. However, since N13 cells are not CD95-sensitive,
caspase-8 is presumably processed in cell death pathways oth-
er than CD95-mediated apoptosis. Consistently, we have ob-
served that caspase-8 is speci¢cally cleaved by a CD95-inde-
pendent mechanism during chemotherapeutic drug-induced
apoptosis [13].
3.3. Activation and regulation of di¡erent caspase members by
ATP
Some forms of apoptosis have been shown to involve the
proteasome pathway [22,23]. Thus, inhibitors of the protea-
some function prevented cell death and activation of caspase-1
in sympathetic neurons following NGF withdrawal [23]. Us-
ing lactacystin, a highly speci¢c inhibitor of the 20S-protea-
some [24], we investigated whether proteasome activity was
required for ATP-induced caspase activation. As shown in
Fig. 3A, lactacystin at a concentration of 2.5 WM almost com-
pletely prevented ATP-induced caspase-1 activation. Interest-
ingly, under the same conditions, processing of caspase-3 (Fig.
3A) and ATP-induced cytotoxicity (Fig. 3B) were not a¡ected.
These results suggest that the proteasome pathway is involved
in the caspase-1 activation but not required for the activation
of caspase-3 and cell death.
3.4. Caspases are involved in ATP-induced apoptotic nuclear
alterations but not cytolytic and membrane damage
To explore the functional involvement of caspases in ATP-
induced cell death, we used peptide inhibitors more speci¢c to
certain caspases. Pretreatment of N13 cells with the broad
spectrum inhibitor zVAD almost completely abrogated
ATP-induced DNA fragmentation as measured by the release
of incorporated BrdU into culture supernatants (Fig. 4A).
YVAD inhibited DNA damage only when applied at high
concentrations (Fig. 4B). In contrast, the BrdU release was
markedly suppressed by DEVD, an inhibitor more selective
for caspase-3 (Fig. 4C). This indicates that presumably casp-
ase-3 rather than caspase-1 was functionally involved in the
ATP-induced DNA fragmentation.
Since P2Z receptor ligation also induces characteristic fea-
FEBS 21738 18-3-99
Fig. 4. The di¡erent e¡ect of caspase inhibitors on ATP-induced
DNA fragmentation and cell viability. N13 cells were either left un-
treated (Co) or treated with 3 mM ATP in the presence of the indi-
cated concentrations of caspase inhibitors zVAD (A), YVAD (B) or
DEVD (C) for 5 h. DNA fragmentation was assessed by released
BrdU using an ELISA (closed symbols). The cell viability was deter-
mined by the release of LDH into supernatants and calculated as
percentage of the total cellular LDH activity (open symbols). Data
represent mean þ S.D. from three experiments.
Fig. 3. Proteasome activity is involved in processing of caspase-1
but not caspase-3. (A) Cells were either left untreated (control) or
incubated for 4 h with ATP in the presence and absence of the indi-
cated concentrations of the proteasome inhibitor lactacystin (LC).
Following SDS-PAGE of cellular lysates, processing of caspase-1
(left panel) and caspase-3 (right panel) was analyzed. (B) The e¡ect
of lactacystin on ATP-induced cytotoxicity. Cells were pretrated
with or without 2.5 WM lactacystin and then exposed to ATP for
4 h. Cell death was measured as described in Fig. 1B.
Fig. 2. P2Z receptor ligation triggers the activation of caspase pro-
teolytic activity. N13 cells were treated with 3 mM ATP and after
the indicated times, cellular lysates were prepared and subjected to
immunoblotting using antibodies against the caspase substrates
PARP and lamin B (A) and individual caspases. Open arrowheads
indicate the full length and closed arrowheads the cleaved forms of
the proteins.
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tures of necrosis, we investigated the e¡ect of the caspase
inhibitors on cell lysis by measuring the cytoplasmic release
of LDH. Within 5 h, ATP induced the release of about 35%
of the maximal LDH activity (Fig. 4A). Pretreatment of cells
with zVAD partially inhibited the LDH release. Surprisingly,
when cells were pretreated with YVAD (Fig. 4B) or DEVD
(Fig. 4C) prior to ATP stimulation, a dose-dependent increase
in the release of LDH was observed. Control experiments
revealed that this increase was not caused by a stimulation
of the LDH enzymatic activity in vitro. In addition, we ob-
served that in contrast to ATP-stimulated cells, the sponta-
neous release of LDH in untreated cells was dose-dependently
inhibited by all caspase inhibitors (data not shown), indicating
that YVAD and DEVD were not toxic on their own.
The role of caspases was further examined by microscopical
evaluation and Hoechst staining of N13 cells. Morphologi-
cally, ATP treatment caused typical necrotic alterations such
as cell swelling and vacuolization of the cytoplasm (Fig. 5).
The nuclei of ATP-treated cells, however, revealed character-
istic apoptotic alterations such as chromatin condensation and
margination, visible by the brightly £uorescent cells. Inhibi-
tion of the caspase activity by zVAD had no signi¢cant e¡ect
on the cytoplasmic morphology and neither cell swelling nor
vacuolization of the cytoplasm were a¡ected. In contrast, the
ATP-induced appearance of nuclear apoptotic morphology
was completely prevented by the caspase inhibitor.
In summary, our experiments reveal several interesting ¢nd-
ings. We demonstrate that stimulation of cells by extracellular
ATP activated caspases selectively through the P2Z purino-
receptor. By the use of lactacystin, it is shown that activation
of caspase-1 but not caspase-3 involves the proteasome path-
way. However, caspase-1 activity is probably not required for
cell death but rather involved IL-1L release [11], which is con-
sistent with the observation that ATP-induced cell death is
comprized neither by lactacystin nor in caspase-1 de¢cient
mice [25]. Finally, we demonstrate that caspases are not re-
quired for all elements of P2Z receptor-mediated cell death.
Although caspase inhibitors prevented apoptotic damage in-
cluding chromatin condensation and DNA fragmentation,
they did inhibit necrotic membrane and lytic alterations.
This suggests that a single death stimulus can simultaneously
initiate pathways leading to both apoptosis and necrosis. The
form of cell death might be determined by the prevalence of a
necrotic or apoptotic signal, but after blockade of one of the
pathways, cells may still die by the other. Interestingly, similar
to our data, inhibition of caspases has been observed to lead
to increased oxidative stress and necrotic damage during
TNF-mediated cytotoxicity in ¢brosarcoma cells [26]. The po-
tentiation of necrotic cell death may therefore constrain a
potential therapeutic use of caspase inhibitors.
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